ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1166

Marijuana Use Amongst Rheumatology Patients: It’s More Common Than Rheumatologists Believe

Rebecca Fitzpatrick1, Najia Shakoor2, Michael Grant2 and Sonali Khandelwal2, 1Rush University Medical Center, Chicago, IL, 2Rush University, Chicago, IL

Meeting: ACR Convergence 2021

Keywords: pain, Surveys

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 8, 2021

Title: Patient Outcomes, Preferences, & Attitudes Poster III: Patient Preferences (1153–1169)

Session Type: Poster Session C

Session Time: 8:30AM-10:30AM

Background/Purpose: With the legalization of marijuana in many states, rheumatologists are having increased inquiries from patients regarding marijuana use in addition to their pain regimen. There are few studies to guide recommendations, and those that exist have mixed findings (Hauser, Journal of Pain 2017). Providers need to understand the prevalence of marijuana use among patients and their views regarding its use so that patients can be guided appropriately. This study assesses rheumatology patients’ and rheumatologists’ perspectives on marijuana use at an urban academic medical clinic.

Methods: Randomly selected patients from an academic rheumatology clinic were consented and enrolled to complete an IRB approved survey. An anonymous survey was given to rheumatology physicians in the same clinic to evaluate their perspectives on marijuana use. Quantitative statistics were used to analyze the data.

Results: Forty-five patients completed the survey. Their demographics and pain assessment are in Table 1. Of the survey responses, 57% of patient had tried marijuana, with 50% using it weekly. Marijuana use was greater in patients over the age of 40 (p=0.05) and in those with a pain score greater than 6 (65%, p=0.01). Patients with no college degree used marijuana more than those with at least a college degree (p=0.02). Of marijuana users, 81% of patients stated that marijuana decreased their pain; 65% reported a decrease in pain medication use. There was no association between marijuana use and ethnicity, diagnosis, or employment status. The majority, 57%, of non-marijuana users were interested in trying it. Table 2 includes patient responses to the survey.

The results of the rheumatologists’ survey are in Table 3. The physician survey found that 66.7% of the rheumatologists believed less than 20% of their patients were using marijuana and a majority felt that younger patients (less than 40) were more likely to use marijuana. Most rheumatologists felt that adding marijuana use to the electronic medical record would be helpful.

Conclusion: At an academic medical center, marijuana use was more common than providers expected and interestingly, more common in older patients. A majority of the patients who were not using marijuana, were interested in trying it. Given that marijuana use is increasing and may now even exceed tobacco use in many practices, it is important to ask about this in all patients. These results also highlight the need for high quality studies on the safety and effects of marijuana use in patients with rheumatic diseases.

Table 1- Patient Survey Demographics

Table 2- Marijuana Preferences Survey Results

Table 3- Rheumatology Provider Responses


Disclosures: R. Fitzpatrick, None; N. Shakoor, DJO/DR. Comfort, 9, 10; M. Grant, None; S. Khandelwal, None.

To cite this abstract in AMA style:

Fitzpatrick R, Shakoor N, Grant M, Khandelwal S. Marijuana Use Amongst Rheumatology Patients: It’s More Common Than Rheumatologists Believe [abstract]. Arthritis Rheumatol. 2021; 73 (suppl 9). https://acrabstracts.org/abstract/marijuana-use-amongst-rheumatology-patients-its-more-common-than-rheumatologists-believe/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2021

ACR Meeting Abstracts - https://acrabstracts.org/abstract/marijuana-use-amongst-rheumatology-patients-its-more-common-than-rheumatologists-believe/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology